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SUPPLEMENTARY TABLE TITLES AND LEGENDS 
Supplementary Table S1, related to Fig. 1. Bulk RNAseq data of genes differentially 
expressed between all ETP samples and Bcl11b-YFP+ DN2a samples. Genes with the 
average RPKM larger than 1, expression fold change larger than 2 either way and 
adjusted pval < 0.05 are shown. Values in RPKM. 
Supplementary Table S2, related to Fig. 2 and Fig. 5. Curated regulatory and marker 
genes used in seqFISH analysis and supervised 10X Chromium analysis. Table 
indicates gene names and the combinations of criteria used for selecting each of these 
genes as particularly informative, based on their genetically defined functional 
importance or use as developmental state indicators (www.immgen.org)(Mingueneau et 
al., 2013)[reviewed in (Longabaugh et al., 2017; Rothenberg et al., 2016; Yui and 
Rothenberg, 2014)].  
Supplementary Table S3, related to Fig. 2.  SeqFISH raw transcript data and analysis 
of transcript distribution comparison between different stages of pro-T cells. Populations 
being compared are Gata3- (≤3 transcripts) and Tcf7- (≤5 transcripts) double negative 
ETPs, Gata3+ (>10 transcripts) or Tcf7+ (>20 transcripts) ETPs, and Bcl11b+ (> 5 
transcripts) DN2s. Thresholds for binning were drawn to identify clear positives and 
negatives and avoid ambiguous intermediate levels of expression. Highlighted are p 
values <10-6, two-tailed T test, unequal variances. Analysis performed from 4-week-
animal dataset. 
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Supplementary Table S4 , related to Fig. 3, Fig. 4, and Fig. S8. C1 and 10X marker 
genes  identified in each sub-cluster in the analyses shown. Clustering based on SLM, 
markers identified with minimum fraction of 0.2 in the cluster and threshold of 0.2 using 
Wilcoxon rank sum test in Seurat 2. C1 supervised analysis was performed as shown in 
Fig.3. 10X unsupervised analysis was performed in Seurat 2 as shown in Fig. 4. 10X 
supervised analysis was performed as described in Fig. S8. pct.1, pct.2: weightings in 
principal components 1, 2 respectively. 
Supplementary Table S5, related to Fig. 5. Differentially expressed genes identified 
by supervised pseudo-time analysis from 10X analysis (intersection of both independent 
10X replicates, qval<1E-08). The genes are ordered and clustered based on the 
pseudotime expression pattern as shown in Fig. 5. The crosses mark the individual 
genes that overlap with perturbation assays, which were shown to be significantly 
regulated by PU.1 or Bcl11b, as described in Fig. 5f-g. Lists of genes regulated by PU.1 
or by Bcl11b were from published data (Hosokawa et al., 2018a, 2018b; Ungerbäck et 
al., 2018) as described in STAR Methods. 
Supplementary Table S6, related to Fig. 2 and STAR methods. Designed oligo 
probe template pools and sequential color barcode used for seqFISH experiments. 
 
 
SUPPLEMENTARY FIGURE LEGENDS 
Supplement to: 
Single-cell analysis reveals regulatory gene expression dynamics in early T cell 
development leading to lineage commitment 
Wen Zhou, Mary A. Yui, Brian A. Williams, Jina Yun, Barbara J. Wold, Long Cai, Ellen 
V. Rothenberg 
 
Supplementary Figure S1, related to Figs. 1, 2, 3, 4, 5, 6, and 7. Summary schematics 
of biological questions addressed and analysis pipelines used.  
A) Summary: logic flow of central biological questions in this study, how each step 
provides the rationale for the next, and breakdown of specific technologies and 
analyses used to address the specific questions. Questions are highlighted in red 
boxes, and results are shaded in gray boxes. Techniques and analysis used are 
described in italic text and colored in background with blue shading indicating analysis 
using single cell transcription profiling tools, purple shading indicating bulk RNA 
analysis, and orange shading indicating cell culturing assays. B) Summarizes 
relationships between methods, gene and cell filters being used, and data analytical 
pipelines used in this study. C) Sorting gates and logistics for purifying Kithi ETP-DN2a 
and DN3 cells for single cell analyses.  
 
Supplementary Figure S2, related to Fig. 2. Highly sensitive seqFISH provides 
reproducible and robust RNA transcript quantitation for regulatory genes.  
A) Scatterplot comparison between mean values of expression measured in a 
comparable population (Flt3+ ETP) in different seqFISH experiments with thymocytes 
from 4, 5, 8-week old animals. B) Scatterplot comparison between mean values of 
expression, measured in seqFISH and 10X Chromium, of genes listed in Table S2. 
Mean values taken from cells in comparable cell populations (Flt3+ ETPs). Patterns 
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were broadly correlated, but seqFISH detected approximately 10 molecules of RNA for 
each UMI count in the 10X analysis (seqFISH: n=1656, from 3 replicates. 10X: n=863, 
from replicate1). The result is consistent with the previously described 10% sampling 
rate of 10X Chromium v2 scRNAseq, at the sequencing depth being used (Islam et al., 
2014; Kolodziejczyk et al., 2015) C) tSNE plots with combined 3 seqFISH replicates, 
including Kit positive and DN3 populations, colored in each panel to indicate the 
distribution of Kit positive cells from one of the individual replicates. The samples from 
different experiments and ages are interspersed without batch corrections. D) Detected 
transcript distribution comparison between seqFISH and 10X Chromium experiment on 
key regulatory genes in ETP-DN2 cells. (seqFISH: n=2524, 10X: n=4234.) SeqFISH 
detected the expression of Notch1, Tcf7, and Runx1 in almost all ETP-DN2 cells, in 
agreement with their known functional roles whereas 10X had a high false negative 
rate. E) Scatterplots of antibody staining and RNA transcript count correlations, colored 
by the cell size estimation (area of image segmentation). F) Transcript and antibody 
distribution of cells at different stages (binned by Il2ra, Bcl11b transcripts). c-Kit and 
TCF1 agree well with Kit and Tcf7 expression at all stages. Note that arrows indicating 
the PU.1 protein (encoded by Spi1) and Spi1 RNA disagree at DN2b stage, as Spi1 
RNA drops in expression between DN2a-b stage while PU.1 protein appears to persist 
longer. This is likely a reflection of the extreme stability of PU.1 protein, as reported 
previously (Kueh et al., 2013). The antibody signals were plotted in arbitrary units on 
linear scales, with signal quantitation described in Methods. G) Developmentally 
ordered clusters of seqFISH transcript distribution. Clusters shown here were as 
presented in Figure 2F, excluding DN3b (cluster 7) and the ‘outlier’ myeloid cluster 
(cluster 8).  
 
Supplementary Figure S3, related to Fig. 4. 10X Chromium scRNAseq replicates 
confirm the similar continuity and heterogeneity of cell states and lineage progression 
within the purified early T cell population. 
 3 
A-B) Scatterplot comparison between mean values of expression measured in 
comparable population (early Flt3+ ETPs) in two 10X Chromium scRNAseq replicates 
(n=863 cells replicate1, n=1442 cells replicate2). C) tSNE display of 10X replicate2 
(7076 cells) colored by cluster. Clustering was performed with SLM algorithm, using PC 
1 to 10. D) Heatmap of feature genes enriched in each sub-cluster analyzed in 10X 
replicate 2, ordered by approximate developmental state. Yellow=high expression, 
purple=low expression. Compare with similar clustering for replicate 1, shown in Fig. 
4D. E) Alignment of seqFISH, 10X, and C1 datasets after CCA scaling, shown in 
principal components 1-2. 
 
Supplementary Figure S4, related to Figs. 2-4. Discrete committed granulocyte 
precursor subset within the immunophenotypically-defined ETP population.  
A) Experimental plan to test developmental potential. Purified Lin-DN thymocyte subsets 
were sorted into wells (25 or 50 cells/well into 96 well plate) for co-culture with pre-
plated OP9 stroma, with Notch ligands (OP9-DL1) or without, and then stained and 
FACs analyzed at indicated timepoints. B) Flt3+, Flt3- ETPs, and DN2a cells cultured on 
OP9-DL1 for 4 days, then analyzed for developmental markers, CD44 and CD25, and 
Bcl11b-YFP. C) CD63+ Ly6c+, and CD63- Ly6c- ETP cells cultured on OP9-DL1 for 4d, 
then analyzed for markers of T-cell progression, CD25, and granulocytes (Gr1). D) 
Summary plot of percentages of CD25+ cells and Gr1+ cells after 4-5d culture with 
OP9-DL1 stromal cells. Thymocytes from Bcl2 transgenic mice were used to enhance 
cell survival. Also see Fig. S5. 
 
Supplementary Figure S5, related to Figs. 2-4. Commitment assays under conditions 
lacking Notch signaling to test ETP subsets for alternative lineage potentials. 
Subsets of ETPs and DN2a cells were sorted according to surface marker expression 
patterns indicated and tested for developmental potential under conditions favoring 
myeloid development. Assays were performed with cells isolated from Bcl2-tg mice to 
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promote survival. 25 or 50 cells/well were plated into 96 well plate with pre-seeded 
OP9-control stroma cells, cultured for 7 days under myeloid conditions, and analyzed by 
flow cytometry as shown. One representative culture is shown from each subset except 
Flt3- ETPs, which are represented by two different cultures. Here, subsets are shown 
with data from the most advanced T-lineage precursors, Bcl11b-YFP+ DN2a cells, which 
are already T-lineage committed. A) Gating strategies and representative flow cytometry 
analysis for alternative lineage assays at day 7 of culture. Cells were gated on FSC and 
SSC, 7AAD negative and CD45 positive for live lymphocytes (top two rows), and then 
separated by anti-NK1.1 + anti-Dx5 and anti-Gr1 for NK cells (NK) and Granulocytes 
(Gr1+ cells) respectively (third row). The non-NK and non-Granulocyte population (lower 
left of panels in third row) was further separated using anti-CD11b and anti-CD11c for 
Macrophage (MP) and Dendritic cells (DC), respectively. The cells that were negative 
for all alternative-lineage markers in the staining panels were categorized as ‘unknown’. 
The cell numbers generated from individual categories were divided by the input cell 
number and displayed in stacked bar graphs in panel (B) and also in Fig. 6E. B) 
Summary graphs for results of alternative lineage potential assays of ETP subsets 
distinguished by Flt3, CD63 and Ly6c expression, compared with DN2a cells separated 
into Bcl11b-YFP- and Bcl11b-YFP+. Isolated cells were cultured on OP9-Control stroma, 
under myeloid lineage supporting cytokine conditions for 7 days (see STAR Methods). 
The stacked bar-graphs represent the developmental potentials of each ETP subset to 
generate cells of non-T lineages under these permissive conditions. Top panel shows 
results from Ly6c-CD63- ETP cells subdivided by Flt3, and DN2a cells subdivided by 
Bcl11b-YFP. The bottom panel shows results from Ly6c and CD63 single and double 
positive ETP populations. Under these conditions, CD63- Ly6c- ETPs generated multiple 
types of cells of alternative non-T lineages, including Gr1+ granulocytes (magenta) (top). 
However, Ly6c+ CD63+ double positive cells gave rise exclusively to Gr1+ granulocytes, 
while CD63+ or Ly6d+ single positive cells generated Gr1+ cells as well as other lineages 
(bottom). Individual replicates are presented in separate bars. 
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Supplementary Figure S6, related to Fig. 4. Resolution of component developmental 
processes: developmental progression coupled with orthogonal spread of cell cycle 
signatures in SPRING analysis.  
A-B) SPRING display of expression topology of ETP-DN2-DN3 cells. Analysis 
performed with PC1-20, and k=5 on raw 10x dataset with cells filtered by minimum 2500 
UMI counts, but not by mitochondrial content, and genes filtered by 60th percentiles for 
variability.  A) Expression levels of key genes are highlighted in green on relative 
scales. The key genes were categorized as early developmental genes (Flt3, Lmo2, and 
Mef2c, early ETPs; Spi1, all ETP and DN2a cells)  and later genes (Il2ra, ETP to DN2a 
transition marker; Fgf3, DN2a-specific; Bcl11b, commitment marker; Rag1, upregulated 
in DN3a) for marking the developmental direction. The second orthogonal axis was 
represented by proliferative and cell cycle state markers, with G2/M-active genes Birc5 
and Mki67 (similarly with Top2a and Cenpa, not shown) expressed by cells at the lower 
right with the highest UMI counts, with G1-to-S phase cyclin Ccne2 immediately 
adjacent, and G1-expressed gene Samhd1 concentrated at the other end). The 
committed granulocyte precursor population appeared as a spur (upper right) away from 
the main distribution (Elane). B) Developmental stages and axes annotated based on 
overall marker expression patterns, with total UMI counts displayed on red-yellow scale 
as shown. 
 
Supplementary Figure S7, related to Fig. 5. Analysis of RNA velocity using Velocyto: 
supporting analysis and minimal interaction of cell cycle with population flux.  
A) Fraction of 10X Chromium reads mapped to different genomic regions: “spliced” 
represents exonic reads, “unspliced” represents intronic reads. B) Mean and variable 
filter of genes that are used in velocity analysis: red dots highlight the gene filter 
(‘spliced’) for PCA analysis. C) PC1-2 display with arrows indicating the transition 
probability of cells (imputation and transitioning probability estimation with k=90, quiver 
scale=0.7, scale type = “relative”.). The vector calculation was performed with (top) and 
without (bottom) including cell cycle genes (as defined by gene ontology annotation 
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(using Goatools), used in (La Manno et al., 2018)). D) Scatterplots (left panels) display 
the un-spliced vs spliced isoform distributions after imputation, and gamma fit of the 
rates of RNA processing for individual genes. Red-blue heatmaps (center plots) 
highlight the unspliced fraction of the individual genes, indicating active synthesis of 
transcripts (red), and apparently decreasing synthesis (blue), on PC1-2 displays as 
shown in (C). Green (right-hand plots) highlight spliced transcripts on the same axes.  
E) PC2-3 display with arrows indicating the transition probability of cells as described in 
the top panel of (C)(and Fig. 5B) plus corresponding gene plots as described in (D). 
 
Supplementary Figure S8, related to Fig. 6. Characterization of ETP subsets based on 
model of developmental pseudotime: transcriptome pseudotime position relative to 
directly tested differentiation kinetics 
Supervised analysis of 10X Chromium data: low dimensional representation based on 
the curated, instructive gene list in Table S2. A) PC loading of first 2 PCs with 
supervised analysis. B) PC (PC1 vs. PC2) and tSNE (tSNE2 vs. tSNE3) displays of 10X 
data (replicate 1, 4627 cells) with clusters color projected. tSNE and the SLM clustering 
algorithm were performed based on PC1-6 (same as seqFISH analysis). C) Clustered 
expression patterns of members of the curated instructive gene list (Table S2) on 
pseudo-time (same pseudo-time scale and calculations as in Fig. 5; displayed are 
genes that were detected in ≥11 cells). Colored by log transformed and row normalized 
relative expression level. D) FACS gating strategy for ETP sub-population sorts in Fig. 
6, both on population level and single cell level. E) Precursors in individual gates shown 
in (D) were profiled for transcriptome expression and pseudotime prediction using Cell 
Hashing. Top panel labels the mean and interquartile ranges of individual-cell 
pseudotime predictions from each subpopulation. Bottom heatmap displays the key 
genes’ expression pattern on this recalculated, ‘ETP-enriched’ pseudotime scale, 
aligned to the top panel. Note enrichment of Tyrobp, Mpo, Cd7, Spi1, and Hhex 
expression corresponding to the sorted ETP subsets 4 and 6. 
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